Skip to main content
. Author manuscript; available in PMC: 2022 Sep 15.
Published in final edited form as: Acta Biomater. 2021 Apr 20;132:345–359. doi: 10.1016/j.actbio.2021.03.076

Figure 6.

Figure 6.

Engineered tumor models assessing tumor immunology and immunotherapy require smart designs. Special considerations should be made in cell-cell interactions of different cell types, connectivity of cell-secreted factors, biomechanics such as fluid pressure and ECM stiffness, and accurate depiction of a 3-D architecture.